Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765232 · ClinicalTrials.gov registry record · Phase 4
Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 111
- Enrollment target
NCT00765232: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00765232 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765232, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having laparoscopic surgery to donate a kidney.
Interventions
- DRUG Placebo
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00765232
The ClinicalTrials.gov registry entry for NCT00765232 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00765232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00765232 about?
NCT00765232 is a clinical study titled "Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy". The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having laparoscopic surgery to donate a kidney.
What is the current status of trial NCT00765232?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 111 participants. The study started on 2008-10. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00765232?
The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT00765232?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.